|
| |
The widened heart shadow and low electrocardiographic voltage that Zondek
originally described are attributable in part to pericardial effusion,
which is echocardiographically demonstrable in 30% of hypo patients. Accumulations
of fluid in the pericardial and other serous spaces of patients with hypo
are the result of both increased plasma albumin egress from blood and decreased
lymphatic clearance of interstitial fluid proteins (42). Pericardial effusions
are seldom hemodynamically significant even when large, presumably because
their slow accumulation permits pericardial compliance. The prevalence
and size of pericardial effusions have been correlated with the severity
of hypo, they typically resolve after 2 to 12 months of T4 therapy.
Rarely, hypo alone may cause heart failure, typically in patients with
severe and prolonged T4 deprivation. However, already in short-term
hypo, a highly significant decrease in myocardial contractility and a prolongation
of diastolic relaxation could be demonstrated (56). Hypo patients with
heart failure have some form of intrinsic cardiac disease on which T4
deficiency has been superimposed. No specific pathophysiologic changes
can be identified that characterise the myxedema heart. The cardiac silhouette
is enlarged, however heart weight is usually normal. Cardiac papillary
muscle obtained from animals with hypo shows a depression of the force
velocity curve and reduced rate of tension development, indicating significant
contractile abnormalities. After administration of T4, all of
these abnormalities revert to normal (57). In addition to decreased direct
effects of T3 in cardiac myocytes, indirect effects occur through
decreases in peripheral oxygen consumption and changes in hemodynamic parameters.
Myofibril swelling with loss of striation and some degree of interstitial
fibrosis occurs on histologic examination of hypo hearts. In addition,
accumulation of mucopolysaccharides can be demonstrated. On electron microscopic
examination, mitochondria show disruption and loss of cristae with lipid
inclusion (5).
|
|